speb/financial-data huggingface dataset:
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 371755000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 216123000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -102027000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -36807000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 30275000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 194845000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 88865000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -36807000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 787451000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -732916000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 105980000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2962360000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 221360000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 77962000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 46325000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 845609000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Normalized Income: 213699600.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 190673000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Operating Income: 391188000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 1982429000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 39540634.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 113339000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 95075000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 5175000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1929261000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 20941000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 38608000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 481000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 79649000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 298340000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 816612000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 968666000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 72779000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Other Special Charges: -1551000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Payables: 687360000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 31972000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 144203000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Pretax Income: 371755000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 2556000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -102027000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -1304637000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -734467000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 916224000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 444802000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 1244000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1244000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -72312000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 468154000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 723669000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 1334912000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1551000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 72477000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 39540634.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 105980000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1005000.00
GENESYS.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 31583000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 4891621000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2962360000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 3012600.00
GENESYS.NS income_statement (annual, 2024-03-31) — Tax Provision: 155632000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
GENESYS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -20494000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 6346027000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 5112986000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 595178000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4907779000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Total Expenses: 1591241000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1438248000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 3032846000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 349735000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 6471000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 92491000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 10042000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 10042000.00
GENESYS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2224668000.00
GENESYS.NS income_statement (annual, 2024-03-31) — Write Off: 2556000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 349451000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1530430000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 250881000.00
GENESYS.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 40108929.00
GENESYS.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 2.80
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 138206000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 198171000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 46622000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1716230000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 198171000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 5102324000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 8450000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 3390570000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 40360000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 424496000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 464856000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1285850000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 30912000.00
GENESYS.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 40543321.00
GENESYS.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 2.77
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 0.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2106971000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 754003000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 5698419000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 250881000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 97846000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 171599000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 269445000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 87587000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 14036000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 549473000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 754003000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2995353000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 205561000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 43000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 39634164.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 143550000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 96611000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 4904153000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 2106971000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 48373000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 745553000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 360000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1669608000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 435873000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 39634164.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 5102324000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2995353000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 6759242000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 5273923000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 734301000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 5116360000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1642882000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 3368672000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 357032000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 86422000.00
GENESYS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2104720000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 223283000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 890857000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 39586590.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 5.22
GENESYS.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 398885000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 156896000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 156896000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 39969439.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 5.17
GENESYS.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — EBIT: 287124000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — EBITDA: 444020000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 491972000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 25752000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 25752000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -536000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 207178000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 207178000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -25752000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -25752000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 444020000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 206642000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Operating Income: 268689000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 890857000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 18435000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 66387000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 261372000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 398885000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 156896000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 54194000.00
GENESYS.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
GENESYS.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 622168000.00
GENESYS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 823069000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 226017000.00
GENESYS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 3110315000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 941642000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 370482000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 370482000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2219947000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2219947000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1399210000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1399210000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 3420825000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3420825000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -69317000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -69317000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Amortization: 288251000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 288251000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 231973000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 231973000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 39677629.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 39721174.00
GENESYS.NS income_statement (annual, 2025-03-31) — Basic EPS: 14.17
GENESYS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.77
GENESYS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 232674000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 243503000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 243503000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -542372000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 123199000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 123199000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 199011000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 199011000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 33436000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 33436000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37292000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37292000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 0.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 33436000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 33436000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -1159602000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -22169000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Change In Payable: 76173000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -815334000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1920932000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -194859000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 199011000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 199011000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5555389000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5555389000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 51396000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 54992000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 54992000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1416237000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 370710000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4551329000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4551329000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 43673000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 43673000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 955338000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 955338000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 999011000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 999011000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1891593000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1891593000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 26083000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 26083000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Depreciation: 550279000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 550279000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 550279000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 152852000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 550279000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 152852000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 39988051.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 39972574.00
GENESYS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 14.06
GENESYS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.74
GENESYS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 189470000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 29000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 29000.00
GENESYS.NS income_statement (annual, 2025-03-31) — EBIT: 914565000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — EBIT: 345987000.00
GENESYS.NS income_statement (annual, 2025-03-31) — EBITDA: 1464844000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 498839000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -4379000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 33436000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 504913000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -1070955000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -196000.00
GENESYS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 91734000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Goodwill: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 2142493000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2142493000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2289264000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2289264000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2121715000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2121715000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Gross Profit: 1694078000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 570932000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 0.00
GENESYS.NS income_statement (annual, 2025-03-31) — Interest Expense: 87803000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 30819000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 87803000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 30819000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Interest Income: 19217000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 19217000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -87803000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 18140000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 6653809000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6653809000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -171189000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 51396000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 676984000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 79526000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 79526000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 143082000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 143082000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 222608000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 222608000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 28161000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -97002000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 94637000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 94637000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 998104000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 998104000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 15433000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 15433000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Minority Interests: 1196000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -503000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 51396000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1064984000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1064984000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -6886000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income: 189470000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 189470000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 561036000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 189973000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 189470000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 189470000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 826762000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 561036000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 189973000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -107797000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -87803000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -30819000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 351813000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 579982000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -68841000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -87803000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -30819000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -217000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 722505000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 722505000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -433705000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 648823000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3412896000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3412896000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 113117000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 113117000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 94637000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 94637000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 207150000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 207150000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1464844000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 498839000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Normalized Income: 562232000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 189470000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -528583000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Operating Income: 871009000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 344915000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 3110315000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 941642000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 39802237.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 39802237.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 87217000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 87217000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 76395000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 76395000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1877000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1877000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 2142493000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2142493000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 74031000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 45163000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 45163000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 43556000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1072000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 272790000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 73165000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 333649000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 333649000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 825116000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 825116000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 2004798000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2004798000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 3856000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3856000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Other Special Charges: -196000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Payables: 835887000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 835887000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 26083000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 26083000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 99020000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 99020000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Pretax Income: 826762000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 315168000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -1590000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -107797000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -434575000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1416237000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 370710000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 550279000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 152852000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 11708000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 11708000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -97002000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 190272000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 190272000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1304364000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1304364000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 351813000.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 870000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 91734000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 39802237.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 39802237.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 648823000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GENESYS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 29683000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5555389000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5555389000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3412896000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3412896000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (annual, 2025-03-31) — Tax Provision: 265726000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 125195000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.32
GENESYS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.40
GENESYS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -110496000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7779660000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7779660000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5698471000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5698471000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1221619000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1221619000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5570822000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5570822000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Total Expenses: 2239306000.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 596727000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2208838000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2208838000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3228331000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3228331000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 317245000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 317245000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 9426000.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 131727000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 131727000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
GENESYS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GENESYS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2659736000.00
GENESYS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2659736000.00
GENESYS.NS income_statement (annual, 2025-03-31) — Write Off: 29172000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 220943000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 708676000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 40681714.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.75
GENESYS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 347043000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 154299000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 154299000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 40915517.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.74
GENESYS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — EBIT: 153429000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 307728000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 361633000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 31829000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 31829000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 1433000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 69760000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 69760000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -31829000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -31829000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 307728000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 71193000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 140690000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 708676000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 12739000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 66644000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 121600000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 347043000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 154299000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 51840000.00
GENESYS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
GENESYS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 567986000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 241177000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 769464000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 339419000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2093763000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 227952000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 41525952.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 2.89
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 101878000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 208595000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 295593000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3664474000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 208595000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6833500000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 36221000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 384543000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 6016429000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 46688000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1273172000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1319860000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2107194000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 156203000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 156203000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 41670139.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.88
GENESYS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — EBIT: 182162000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 338365000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2099322000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 585931000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 384921000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 31037000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 31037000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8198491000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 227952000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 55190000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 91819000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 147009000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 99675000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 15045000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -507000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1069398000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 120517000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 120517000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -31037000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -31037000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 585931000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4734178000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 111804000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 9785000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 338365000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 120010000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 143744000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 769464000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 41718912.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 257832000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 58195000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6624905000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2099322000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 148720000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 38418000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 84974000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 549710000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 360000.00